The overall objectives of this proposal is to investigate the role of PI 3- kinase in c-kit receptor mediated processes in vivo and in vitro. The proto-oncogene c-kit, encodes a receptor tyrosine kinase (RTK) which belongs to a family of receptors that includes the platelet- derived growth factor (PDGF). The ligand of the c-kit receptor, designated KL, encodes a cell surface molecule which may be processed to produce a soluble product. Whereas the c-kit gene is allelic with the white spotting locus (W) in the mouse, kit-ligand (KL) is allelic with the steel locus (Sl) in the mouse. W and Sl mutations affect various aspects of hematopoiesis, including the stem cell compartment, gametogenesis during embryonic development and in the adult animal, causing macrocytic anemia, mast cell deficiency anemia, mast cell deficiency, spotting, male and female sterility and megacolon. Based on mutant phenotypes the cellular responses mediated by the c- kit receptor are quite diverse and include: cell proliferation, cell survival, cell adhesion, cell migration, secretion of mediators, cell differentiation and other post mitotic functions. The elucidation of the mechanisms of these different responses is of fundamental importance. Similar to other RTK's Kit mediates its action through a variety of cytoplasmic signal transducers including PI 3-kinase in KIT mediated adhesion of BMMC to a fibronectin matrix and potentiation of IgE mediated secretion in BMMC. To study Kit/PI 3-kinase mediated processes in other cell systems we will modify the c-kit gene in the germ line to mutate the PI 3-kinase binding site in the Kit receptor by using a cre-lox based strategy and derive mice homozygous for this mutation. We then will study the effect of the mutation on various targets of W and SI mutations, the dynamics of hematopoietic cell populations and their behavior in situations that require cell adhesion and migration, i.e. homing to the marrow compartment and mobilization of stem cells into the periphery. We will also modify tyrosine residues in the juxtamembrane region of the Kit receptor in ES cells which affect KL mediated cell proliferation but not suppression of apoptosis and investigate the consequences of this mutation in vivo. Finally, we will investigate the mechanism of Kit mediated suppression of radiation and factor deprivation induced apoptosis in mast cells.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL055748-01A2
Application #
2407336
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1997-08-01
Project End
2001-06-30
Budget Start
1997-08-01
Budget End
1998-06-30
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Bosbach, Benedikt; Rossi, Ferdinand; Yozgat, Yasemin et al. (2017) Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor. Proc Natl Acad Sci U S A 114:E8448-E8457
Buono, Mario; Facchini, Raffaella; Matsuoka, Sahoko et al. (2016) A dynamic niche provides Kit ligand in a stage-specific manner to the earliest thymocyte progenitors. Nat Cell Biol 18:157-67
Roset, Ramon; Inagaki, Akiko; Hohl, Marcel et al. (2014) The Rad50 hook domain regulates DNA damage signaling and tumorigenesis. Genes Dev 28:451-62
Cao, Zhongwei; Ding, Bi-Sen; Guo, Peipei et al. (2014) Angiocrine factors deployed by tumor vascular niche induce B cell lymphoma invasiveness and chemoresistance. Cancer Cell 25:350-65
Sandler, Vladislav M; Lis, Raphael; Liu, Ying et al. (2014) Reprogramming human endothelial cells to haematopoietic cells requires vascular induction. Nature 511:312-8
Deshpande, Shayu; Bosbach, Benedikt; Yozgat, Yasemin et al. (2013) KIT receptor gain-of-function in hematopoiesis enhances stem cell self-renewal and promotes progenitor cell expansion. Stem Cells 31:1683-95
Chen, Junwei; Guo, Tianhua; Zhang, Lei et al. (2012) CD133 and CD44 are universally overexpressed in GIST and do not represent cancer stem cell markers. Genes Chromosomes Cancer 51:186-95
Bosbach, Benedikt; Deshpande, Shayu; Rossi, Ferdinand et al. (2012) Imatinib resistance and microcytic erythrocytosis in a KitV558ýý;T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor. Proc Natl Acad Sci U S A 109:E2276-83
Balachandran, Vinod P; Cavnar, Michael J; Zeng, Shan et al. (2011) Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nat Med 17:1094-100
Chen, Yu; Shamu, Tambudzai; Chen, Hui et al. (2011) Visualization of the interstitial cells of cajal (ICC) network in mice. J Vis Exp :

Showing the most recent 10 out of 24 publications